Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 84 total PSOs listed by AHRQ.

CHPSO
PSO Number: P0002
Component of Parent Org(s):
  • California Association of Hospitals and Health Systems (CAHHS)
  • Hospital Quality Institute (HQI)
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 1215 K Street, Suite 930, Sacramento, California 95814
PSO Phone Number: (916) 552-2600
Point of Contact: Rory Jaffe MD, MBA
Point of Contact Phone: (916) 552-7568
Point of Contact Email: rjaffe@chpso.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Center for Patient Safety
PSO Number: P0011
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 2410A Hyde Park Road, Jefferson City, Missouri 65109
PSO Phone Number: (573) 636-1014
Point of Contact: Alexandra Christgen
Point of Contact Phone: (573) 636-1014
Point of Contact Email: achristgen@centerforpatientsafety.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Clarity PSO
PSO Number: P0015
Component of Parent Org(s):
  • Clarity Group, Inc.
Effective Date and Time of Initial Listing: November 19, 2008 12:01 AM ET
Street Address: 8725 W Higgins Road, Suite 810, Chicago, Illinois 60631
PSO Phone Number: (773) 867-8066
Point of Contact: Thomas F. Piotrowski
Point of Contact Phone: (773) 867-8066
Point of Contact Email: tpiotrowski@claritypso.com (link is external)
Next biennial attestation for Two Contracts due between 11/19/2018 and 11/18/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
ECRI Institute PSO
PSO Number: P0008
Component of Parent Org(s):
  • ECRI Institute
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 5200 Butler Pike, Plymouth Meeting, Pennsylvania 19462
PSO Phone Number: (866) 247-3004
Point of Contact: William M. Marella
Point of Contact Phone: (610) 825-6000, ext. 5173
Point of Contact Email: WMarella@ECRI.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
HCA Patient Safety Organization, LLC
PSO Number: P0157
Component of Parent Org(s):
  • HCA Holdings, Inc. (direct parent: EP Holdco, LLC)
Effective Date and Time of Initial Listing: April 9, 2014 12:01 AM ET
Street Address: One Park Plaza, Nashville, Tennessee 37203
PSO Phone Number: (615) 344-2293
Point of Contact: Sharon Weidner Hickman
Point of Contact Phone: 615-344-1254
Point of Contact Email: Sharon.Hickman@hcahealthcare.com (link is external)
Next biennial attestation for Two Contracts due between 04/09/2018 and 04/08/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
HPI Press Ganey PSO
PSO Number: P0185
Component of Parent Org(s):
  • Press Ganey
Effective Date and Time of Initial Listing: December 12, 2016 12:01 AM ET
Street Address: 5041 Corporate Woods Drive Ste 180, Virginia Beach, Virginia 23462
PSO Phone Number: (202) 740-6174
Point of Contact: Caryn Lea Woods
Point of Contact Phone: (913) 800-4954
Point of Contact Email: caryn.woods@pressganey.com (link is external)
Next biennial attestation for Two Contracts due between 12/12/2018 and 12/11/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Institute for Safe Medication Practices (ISMP)
PSO Number: P0009
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 200 Lakeside Drive, Suite 200, Horsham, Pennsylvania 19044
PSO Phone Number: (215) 947-7797
Point of Contact: Ann D. Shastay RN, MSN, AOCN
Point of Contact Phone: (215) 947-7797
Point of Contact Email: ashastay@ismp.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Louisiana Alliance for Patient Safety PSO
PSO Number: P0186
Component of Parent Org(s):
  • Louisiana Hospital Association
Effective Date and Time of Initial Listing: November 8, 2016 12:01 AM ET
Street Address: 9521 Brookline Ave, Baton Rouge, Louisiana 70809
PSO Phone Number: (225) 928-0026
Point of Contact: Floyd J. Roberts Jr., MD, FACP, FCCP
Point of Contact Phone: 225-928-0026, ext. 206
Point of Contact Email: froberts@lhaonline.org (link is external)
Next biennial attestation for Two Contracts due between 11/08/2018 and 11/07/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Vizient™ PSO
PSO Number: P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 155 North Wacker Drive, Suite 4000, Chicago, Illinois 60606
PSO Phone Number: (312) 775-4100
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Next biennial attestation for Two Contracts due between 11/05/2020 and 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No